Advertisement

Clinical and Translational Oncology

, Volume 20, Issue 4, pp 557–558 | Cite as

Correction to: High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells

  • Z. Zhao
  • Y. Xu
  • J. Lu
  • J. Xue
  • P. Liu
Correction
  • 510 Downloads

Correction to: Clin Transl Oncol DOI 10.1007/s12094-017-1738-7

In the original version of the article, Table 2 was incorrect. The corrected Table 2 is shown here. Therefore, in Results (page 3 of original version, right column, line 13), the OR of non-optimal debulking should read OR = 3.036 with 95% CI 1.452–6.348.
Table 2

Relationships between the expression of HO-1 protein and clinicopathological characteristics of patients with ovarian cancer

Characteristics

No.

HO-1 expression

P value

OR (95% CI)

Cases

Low

High

Pathologic type

0.0235

 

Serous

117

36

81 (69.2%)

0.6912

 

 Low-grade serous

58

19

39 (67.2%)

 

 High-grade serous

59

17

42(71.2%)

 

Mucinous

16

11

5 (31.3%)

 

Endometrioid

25

8

17 (68.0%)

 

Clear cell carcinoma

21

11

10 (47.6%)

 

Others

22

8

14 (63.6%)

 

Age

0.4796

 

 ≤ 50

113

44

69 (61.1%)

  

 > 50

88

30

58 (65.9%)

  

Stage

0.0017

3.656 (1.602–8.344)

 I–II

154

66

88 (57.1%)

  

 III–IV

47

8

39 (83.0%)

Differentiation

0.5572

 

 G1/G2

112

39

73 (65.2%)

  

 G3

89

35

54 (60.7%)

Lymph node metastasisa

0.0001

7.779 (2.280–26.540)

 No

156

67

89 (57.1%)

  

 Yes

34

3

31 (91.2%)

Optimal debulking

0.0029

3.036 (1.452–6.348)

 Optimal

146

63

83 (56.8%)

  

 Non-optimal

55

11

44 (80.0%)

aEleven patients without lymph node resection

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2017

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyQilu Hospital of Shandong UniversityJinanPeople’s Republic of China

Personalised recommendations